Literature DB >> 7447768

Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects.

M F Armaly, D E Krueger, L Maunder, B Becker, J Hetherington, A E Kolker, R Z Levene, A E Maumenee, I P Pollack, R N Shaffer.   

Abstract

A prospective collaborative study was conducted in five centers during a 13-year period to identify factors that influence the development of visual-field defects (GVFDs) of open angle glaucoma. In 5,000 subjects, GVFDs developed in only 1.7% of eyes. Statistical analysis of 26 factors at first examination identified five that were significantly related to the development of GVFDs--outflow facility, age, applanation pressure, cup-disc ratio, and pressure change after water drinking. Their absolute initial value, and not its change with time, was the important predictor. Multivariate analysis showed their collective predictive power to be undesirably poor, indicating that other factors must play an important role in the development of GVFDs. Mortality-table analysis indicated that during a period of five years, 98.54% of eyes with initial pressure less than 20 mm Hg continued to be free from GVFDs as compared with 93.34% of those with pressure of 20 mm Hg or greater.

Entities:  

Mesh:

Year:  1980        PMID: 7447768     DOI: 10.1001/archopht.1980.01020041015002

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  68 in total

1.  Different types of optic disc shape in patients with advanced open-angle glaucoma.

Authors:  Toru Nakazawa; Nobuo Fuse; Kazuko Omodaka; Naoko Aizawa; Souichiro Kuwahara; Kohji Nishida
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

2.  Correlation between intraocular pressure obtained with water drinking test versus modified diurnal tension curve measurement in pseudoexfoliation glaucoma.

Authors:  Penpe Gül Firat; Seyhan Dikci; İlknur Tuncer Firat; Soner Demirel; Murat Firat; Emrah Öztürk; Zarife Ekici Gök
Journal:  Int Ophthalmol       Date:  2021-04-20       Impact factor: 2.031

3.  Changes in visual field defects during 10-year follow-up for indocyanine green-assisted macular hole surgery.

Authors:  Masanori Nakazawa; Hiroto Terasaki; Takehiro Yamashita; Akinori Uemura; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2016-06-07       Impact factor: 2.447

4.  Neovibsanin B increases extracellular matrix proteins in optic nerve head cells via activation of Smad signalling pathway.

Authors:  Zhen Wang; Wei Xu; Ao Rong; Yan Lin; Xu-Ling Qiu; Shen Qu; Xian-Hai Lan
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

5.  Changing concepts of primary open-angle glaucoma and early detection.

Authors:  R N Battista; P Huston; M W Davis
Journal:  Can Fam Physician       Date:  1986-07       Impact factor: 3.275

6.  Genetic heterogeneity of primary open angle glaucoma and ocular hypertension: linkage to GLC1A associated with an increased risk of severe glaucomatous optic neuropathy.

Authors:  A P Brézin; A Béchetoille; P Hamard; F Valtot; M Berkani; A Belmouden; M F Adam; S Dupont de Dinechin; J F Bach; H J Garchon
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

7.  Impaired motion sensitivity as a predictor of subsequent field loss in glaucoma suspects: the Roscommon Glaucoma Study.

Authors:  J Wu; M Coffey; A Reidy; R Wormald
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

Review 8.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

9.  First-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprost.

Authors:  Simon K Law
Journal:  Clin Ophthalmol       Date:  2007-09

10.  Correlation between central corneal thickness and intraocular pressure peak and fluctuation during the water drinking test in glaucoma patients.

Authors:  Rafael Lacerda Furlanetto; Antonio Carlos Facio; Marcelo Hatanaka; Remo Susanna Junior
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.